Show simple item record

Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia A Pooled Analysis of More Than 1 Million Participants

dc.contributor.authorYang, Jae Jeong
dc.contributor.authorYu, Danxia
dc.contributor.authorWen, Wanqing
dc.contributor.authorShu, Xiao-Ou
dc.contributor.authorCai, Hui
dc.contributor.authorZheng, Wei
dc.date.accessioned2020-06-25T23:36:49Z
dc.date.available2020-06-25T23:36:49Z
dc.date.issued2019-04
dc.identifier.citationYang JJ, Yu D, Wen W, et al. Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants. JAMA Netw Open. 2019;2(4):e192696. Published 2019 Apr 5. doi:10.1001/jamanetworkopen.2019.2696en_US
dc.identifier.issn2574-3805
dc.identifier.urihttp://hdl.handle.net/1803/10073
dc.descriptionOnly Vanderbilt University affiliated authors are listed on VUIR. For a full list of authors, access the version of record at https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2730789en_US
dc.description.abstractIMPORTANCE Asia is home to the largest diabetic populations in the world. However, limited studies have quantified the association of diabetes with all-cause and cause-specific mortality in Asian populations. OBJECTIVES To evaluate the association of diabetes with all-cause and cause-specific mortality in Asia and to investigate potential effect modifications of the diabetes-mortality associations by participants' age, sex, education level, body mass index, and smoking status. DESIGN, SETTING, AND PARTICIPANTS This pooled analysis incorporated individual participant data from 22 prospective cohort studies of the Asia Cohort Consortium conducted between 1963 and 2006. A total of 1 002 551 Asian individuals (from mainland China, Japan, South Korea, Singapore, Taiwan, India, and Bangladesh) were followed up for more than 3 years. Cohort-specific hazard ratios and 95% confidence intervals for all-cause and cause-specific mortality were estimated using Cox regression models and then pooled using random-effects meta-analysis. Analysis was conducted between January 10, 2018, and August 31, 2018. EXPOSURES Doctor-diagnosed diabetes, age, sex, education level, body mass index, and smoking status. MAIN OUTCOMES AND MEASURES All-cause and cause-specific mortality. RESULTS Of 1 002 551 participants (518 537 [51.7%] female; median [range] age, 54.0 [30.0-98.0] years), 148 868 deaths were ascertained during a median (range) follow-up of 12.6 (3.0-38.9) years. The overall prevalence of diabetes reported at baseline was 4.8% for men and 3.6% for women. Patients with diabetes had a 1.89-fold risk of all-cause death compared with patients without diabetes (hazard ratio [HR], 1.89; 95% CI, 1.74-2.04), with the highest relative risk of death due to diabetes itself (HR, 22.8; 95% CI, 18.5-28.1), followed by renal disease (HR, 3.08; 95% CI, 2.50-3.78), coronary heart disease (HR, 2.57; 95% CI, 2.19-3.02), and ischemic stroke (HR, 2.15; 95% CI, 1.85-2.51). The adverse diabetes-mortality associations were more evident among women (HR, 2.09; 95% CI, 1.89-2.32) than among men (HR, 1.74; 95% CI, 1.62-1.88) (P for interaction < .001) and more evident among adults aged 30 to 49 years (HR, 2.43; 95% CI, 2.08-2.84) than among adults aged 70 years and older (HR, 1.51; 95% CI, 1.40-1.62) (P for interaction < .001). A similar pattern of association was found between diabetes and cause-specific mortality, with significant variations noted by sex and age. CONCLUSIONS AND RELEVANCE This study found that diabetes was associated with increased risk of death from several diseases among Asian populations. Development and implementation of diabetes management programs are urgently needed to reduce the burden of diabetes in Asia.en_US
dc.description.sponsorshipThis work was supported by research funds from the Anne Potter Wilson Chair endowment and National Institutes of Health (NIH) grants (UM1CA182910 to Dr Zheng and UM1CA173640 to Dr Shu) at Vanderbilt University Medical Center. Participating cohort studies in the consortium are as follows: China National Hypertension Survey Epidemiology Follow-up Study (funded by American Heart Association grant 9750612N, National Heart, Lung, and Blood Institute grant U01-HL072507, and the Chinese Academy of Medical Sciences); Shanghai Cohort Study (funded by NIH grants R01CA0403092, R01CA144034, and UM1CA182876); Shanghai Men's Health Study (funded by NIH grant R01-CA82729); Shanghai Women's Health Study (funded by NIH grant R37-CA70867); Korea Multi-center Cancer Cohort (funded by Ministry of Education, Science and Technology, Korea, National Research Foundation of Korea grant 2009-0087452); Seoul Male Cancer Cohort (funded by National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea grant 0520160-1); Singapore Chinese Health Study (funded by NIH grants R01CA55069, R35CA53890, R01CA80205, R01CA144034, and UM1CA182876); Community-Based Cancer Screening Project (funded by the National Science Council and Department of Health, Taiwan); Cardiovascular Disease Risk Factor Two-Township Study (funded by Department of Health, Taiwan, grants DOH80-27, DOH81-021, DOH8202-1027, DOH83-TD-015, and DOH84-TD-006); Health Effects of Arsenic Longitudinal Study (funded by NIH grants P42ES010349, R01CA102484, and R01CA107431); and Mumbai Cohort Study (funded by the International Agency for Research on Cancer, Clinical Trials Service Unit/Oxford University, and the World Health Organization); and Life Span Study (funded by the Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan, a private, nonprofit foundation funded by the Japanese Ministry of Health, Labour and Welfare and the US Department of Energy (DOE), the latter in part through DOE grant DE-HS0000031 to the National Academy of Sciences, and RERF Research Protocol RP-A03-10. The Three Prefecture Cohort Study Aichi, Ibaraki Prefectural Health Study, Japan Collaborative Cohort Study, Japan Public Health Center-based Prospective Study, Three Prefecture Cohort Study Miyagi, Miyagi Cohort Study, and Ohsaki National Health Insurance Cohort Study are supported by the Grant-in-aid for Cancer Research, Grant for the Third Term Comprehensive Control Research for Cancer, Grant for Health Services, Grant for Medical Services for Aged and Health Promotion, and Grant for Comprehensive Research on Cardiovascular and Life-style Related Diseases from the Ministry of Health, Labour and Welfare, Japan; and the Grant for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The Japan Public Health Center-Based Prospective Study and Takayama Study are also supported by the National Cancer Center Research and Development Fund.en_US
dc.language.isoen_USen_US
dc.publisherJAMA Network Openen_US
dc.rightsThis is an open access article distributed under the terms of the CC-BY License. © 2019 Yang JJ et al. JAMA Network Open.
dc.source.urihttps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2730789
dc.subjectCANCER-MORTALITYen_US
dc.subjectRISK-FACTORen_US
dc.subject64 COHORTSen_US
dc.subjectONE-STAGEen_US
dc.subjectMELLITUSen_US
dc.subjectMETAANALYSISen_US
dc.subjectINDIVIDUALSen_US
dc.subjectDEATHen_US
dc.subjectMENen_US
dc.subjectPOPULATIONen_US
dc.titleAssociation of Diabetes With All-Cause and Cause-Specific Mortality in Asia A Pooled Analysis of More Than 1 Million Participantsen_US
dc.typeArticleen_US
dc.identifier.doi10.1001/jamanetworkopen.2019.2696


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record